These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 24452843

  • 21. Subacute cutaneous lupus erythematosus in a patient with Sjögren's syndrome taking terbinafine for onychomycosis.
    Madeira N, Silva C, Cunha-Miranda L.
    Acta Reumatol Port; 2020; 45(4):288-292. PubMed ID: 33420774
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.
    Xu K, Zhang M, Yang S, Yu G, Zheng P, Qin X, Feng J.
    BMC Neurol; 2023 Apr 26; 23(1):168. PubMed ID: 37101279
    [Abstract] [Full Text] [Related]

  • 27. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J, Meunier B, Lardet D, Dicostanzo MP, Rouby F, Terrier JP, Harlé JR, Richard MA, Chiche L.
    Ann Dermatol Venereol; 2014 Oct 26; 141(10):593-7. PubMed ID: 25288062
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?
    Lis-Święty A, Brzezińska-Wcisło L, Widuchowska M, Kucharz E.
    Immunopharmacol Immunotoxicol; 2013 Jun 26; 35(3):443-6. PubMed ID: 23537059
    [Abstract] [Full Text] [Related]

  • 30. Rowell's syndrome induced by terbinafine.
    Murad A, Shudell E, Mulligan N.
    BMJ Case Rep; 2015 May 28; 2015():. PubMed ID: 26021384
    [Abstract] [Full Text] [Related]

  • 31. Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
    Marano AL, Clarke JM, Morse MA, Shah A, Barrow W, Selim MA, Hall RP, Cardones AR.
    Br J Dermatol; 2019 Sep 28; 181(3):580-583. PubMed ID: 30244487
    [Abstract] [Full Text] [Related]

  • 32. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV, Lazzari R, Polloni I, Crosti C, Fabbri P, Cugno M.
    Br J Dermatol; 2011 Aug 28; 165(2):335-41. PubMed ID: 21564069
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
    Deng Z, Guo A, Wu C, Wang C.
    J Cosmet Dermatol; 2022 Dec 28; 21(12):7202-7208. PubMed ID: 36214602
    [Abstract] [Full Text] [Related]

  • 35. Subacute cutaneous lupus erythematosus induced by nifedipine.
    Gubinelli E, Cocuroccia B, Girolomoni G.
    J Cutan Med Surg; 2003 Dec 28; 7(3):243-6. PubMed ID: 12574905
    [Abstract] [Full Text] [Related]

  • 36. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV, Vezzoli P, Crosti C.
    Lupus; 2009 Oct 28; 18(11):935-40. PubMed ID: 19762393
    [Abstract] [Full Text] [Related]

  • 37. Drug-induced lupus erythematosus.
    Marzano AV, Tavecchio S, Menicanti C, Crosti C.
    G Ital Dermatol Venereol; 2014 Jun 28; 149(3):301-9. PubMed ID: 24819757
    [Abstract] [Full Text] [Related]

  • 38. Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy.
    Funke AA, Kulp-Shorten CL, Callen JP.
    Arch Dermatol; 2010 Oct 28; 146(10):1113-6. PubMed ID: 20956642
    [Abstract] [Full Text] [Related]

  • 39. [Terbinafine : Drug-induced lupus erythematodes and triggering of psoriatic skin lesions].
    Mayser P.
    Hautarzt; 2016 Sep 28; 67(9):724-31. PubMed ID: 27455869
    [Abstract] [Full Text] [Related]

  • 40. Severe Rowell syndrome associated with oral terbinafine.
    Champagne C, Ratnavel R, Wong T.
    Clin Exp Dermatol; 2012 Oct 28; 37(7):822-3. PubMed ID: 22998546
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.